Gen-Probe Incorporated
Gen-Probe exercises option to develop rapid molecular testing platform using Qualigen patent
Published in Medical Patent Law Weekly, May 17th, 2006
As part of the exercise, Gen-Probe has purchased preferred stock convertible into approximately 19.5% of Qualigen's fully diluted common shares for approximately $7 million.
If development is successful, the new platform, known as a closed unit-dose assay (CUDA) system, would use Gen-Probe's NAT technologies to rapidly detect, at the point of sample collection, the presence of harmful microorganisms and genetic mutations. The platform could...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Cutting Edge Information
Cutting Edge Information study finds patent litigation is a bargain at $15 million - Kyphon, Inc.
Kyphon responds to lawsuit over patents for catheter and spinal fracture treatment - Medtronic, Inc.
Medtronic sues Kyphon for patent infringement - iCAD, Inc.
ICAD wins patent arbitration defense; panel finds no infringement - Anodyne Therapy, LLC
New studies published on photo-energy treatment device show pain reduction benefits - Argos Therapeutics
Argos, Beckman Coulter sign license agreement - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
